Inventor · disambiguated record
Andrew Marks
Also filed as: MARKS ANDREW · MARKS ANDREW R · MARKS ANDREW ROBERT
11 granted patents·20 pending applications·75 citations·filing 2000–2025
89Inventor score
Files withUNIV COLUMBIA20MARKS ANDREW ROBERT2MARX STEVEN1OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE TRUSTEES1OF NEW YORK THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY1
Top patents by PatentIndex Score
31 records- 0189US7544678B2Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)UNIV COLUMBIA·Filed 2005·Granted Jun 9, 2009·6 cites·5 claims
- 0286US7879840B2Agents for preventing and treating disorders involving modulation of the RyR receptorsUNIV COLUMBIA·Filed 2006·Granted Feb 1, 2011·6 cites·38 claims
- 0384US6489125B1Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptorUNIV COLUMBIA·Filed 2000·Granted Dec 3, 2002·29 cites·17 claims
- 0483US7393652B2Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)UNIV COLUMBIA·Filed 2005·Granted Jul 1, 2008·9 cites·8 claims
- 0582US8022058B2Agents for preventing and treating disorders involving modulation of the RyR receptorsUNIV COLUMBIA·Filed 2005·Granted Sep 20, 2011·6 cites·116 claims
- 0675US8710045B2Agents for preventing and treating disorders involving modulation of the ryanodine receptorsMARKS ANDREW ROBERT·Filed 2010·Granted Apr 29, 2014·5 cites·20 claims
- 0775US7662178B2C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosisUNIV COLUMBIA·Filed 2008·Granted Feb 16, 2010·4 cites·64 claims
- 0873US7312044B2Type 1 ryanodine receptor-based methodsUNIV COLUMBIA·Filed 2004·Granted Dec 25, 2007·7 cites·10 claims
- 0972US2023386615A1Binding site in type 1 ryanodine receptorUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 1067US2023368862A1Binding site in type 2 ryanodine receptorUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 1163US2023302013A1METHOD OF TREATING VIRAL-INDUCED COGNITIVE DYSFUNCTION BY TARGETING LEAKY RyR2 CHANNELSUNIV COLUMBIA·Filed 2023·Application pending·0 cites
- 1262US10925976B2Smooth muscle specific inhibition for anti-restenotic therapyUNIV COLUMBIA·Filed 2017·Granted Feb 23, 2021·0 cites·15 claims
- 1359US7364586B2C3 exoenzyme-coated stents and uses thereof for treating and preventing restenosisUNIV COLUMBIA·Filed 2002·Granted Apr 29, 2008·3 cites·11 claims
- 1459US2009274739A1Methods and compositions for treating neointimal hyperplasiaUNIV COLUMBIA·Filed 2008·Application pending·0 cites
- 1556US2015190532A1Smooth muscle specific inhibition for anti-restenotic therapyUNIV COLUMBIA·Filed 2013·Application pending·0 cites
- 1655US2010152440A1NOVEL ANTI-ARRHYTHMIC AND HEART FAILURE DRUGS THAT TARGET THE LEAK IN THE RYANODINE RECEPTOR (RyR2)MARKS ANDREW ROBERT·Filed 2009·Application pending·0 cites
- 1752US2014187536A1Agents for preventing and treating disorders involving modulation of the ryanodine receptorsUNIV COLUMBIA·Filed 2014·Application pending·0 cites
- 1848US2004213826A1Medical devices and methods for inhibiting proliferation of smooth muscle cellsFiled 2003·Application pending·0 cites
- 1948US2009004756A1Methods for identifying agents that target leaks in ryanodine receptorsUNIV COLUMBIA·Filed 2008·Application pending·0 cites
- 2047US7718644B2Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereofUNIV COLUMBIA·Filed 2004·Granted May 18, 2010·0 cites·29 claims
- 2147US2003013638A1P27 prevents cellular migrationFiled 2002·Application pending·0 cites
- 2245US2003134331A1Controlling pathways that regulate muscle contraction in the heartUNIV COLUMBIA·Filed 2002·Application pending·0 cites
- 2345US2004229781A1Compounds and methods for treating and preventing exercise-induced cardiac arrhythmiasFiled 2003·Application pending·0 cites
- 2444US2025255882A1Treatment of cardiac condition related cognitive dysfunctionUNIV COLUMBIA·Filed 2025·Application pending·0 cites
- 2544US2004028716A1Use of Y-27632 as an agent to prevent restenosis after coronary artery angioplasty/stent implantationFiled 2003·Application pending·0 cites
- 2644US2004048780A1Method for treating and preventing cardiac arrhythmiaUNIV COLUMBIA·Filed 2003·Application pending·0 cites
- 2742US2006293266A1Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failureTRUSTEES OF COLUMBIA·Filed 2005·Application pending·0 cites
- 2842US2014127228A1Inhibition of tgfbeta signaling to improve muscle function in cancerOF NEW YORK THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY·Filed 2013·Application pending·0 cites
- 2942US2014128349A1Administering inhibitors of tgfbeta signaling in combination with benzothiazepine derivatives to improve muscle function in cancer patientsOF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE TRUSTEES·Filed 2013·Application pending·0 cites
- 3037US2002098998A1P27 prevents cellular migrationFiled 2001·Application pending·0 cites
- 3130US2012184517A1Treatment of diseases with altered smooth muscle contractilityMARX STEVEN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Marks files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →